Market revenue in 2023 | USD 38.9 million |
Market revenue in 2030 | USD 292.8 million |
Growth rate | 33.4% (CAGR from 2023 to 2030) |
Largest segment | Software solutions |
Fastest growing segment | Software Solutions |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Software Solutions, Hardware, Services |
Key market players worldwide | International Business Machines Corp, Siemens Healthineers AG ADR, Intel Corp, GE HealthCare Technologies Inc Common Stock, NVIDIA Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai in oncology market will help companies and investors design strategic landscapes.
Software solutions was the largest segment with a revenue share of 48.84% in 2023. Horizon Databook has segmented the Sweden ai in oncology market based on software solutions, hardware, services covering the revenue growth of each sub-segment from 2018 to 2030.
The AI in oncology market in Sweden is in the developing phase. Several research institutes are undertaking numerous initiatives to explore the potential of AI in the oncology domain. For instance, in December 2023,Sodersjukhuses an emergency care hospital in Sweden, announced that it is expected to launch a study, SMART, using AI to detect breast cancer in April 2024.
The study involves 70,000 women aged 40 to 74 suffering from breast cancer who are undergoing screenings at the Soders jukhuses. Among the participants, 35,000 are expected to undergo screening every 2 years, following the standard interval protocol.
In November 2023, researchers from Karolinska Institute and SciLife Lab in Sweden employed an innovative AI approach to analyze extensive datasets derived from tumor tissue. This method can potentially advance the development of highly personalized cancer treatments.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden ai in oncology market , including forecasts for subscribers. This country databook contains high-level insights into Sweden ai in oncology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account